Agenus | AGEN - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
AbbVie USD 64.53B 5.59B 2026-03
Agenus USD 153.98M 15.68M 2026-03
Amgen USD 51.86B 27M 2026-06
AstraZeneca USD 26.01B 46M 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
CSL USD 10.42B 273M 2025-12
Eli Lilly USD 47.86B 8.49B 2026-06
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 13.95B 65M 2026-06
Glaxosmithkline GBP 18.53B 1.29B 2026-03
Incyte USD 28.42M 994K 2026-06
Intrexon USD 0 198.67M 2024-06
J&J USD 37.34B 183M 2026-06
Jiangsu Hengrui CNY 38.23M 1.13M 2026-06
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
MacroGenics USD 68.71M 1.29M 2026-03
Merck EUR 11.21B 406M 2026-06
Merck USD 51.08B 4.41B 2026-06
Northwest Biotherapeutics USD 16.21M 15.59M 2026-03
Novartis USD 37.49B 42M 2026-06
Novavax USD 246.3M 200K 2025-12
Pfizer USD 60.5B 70M 2026-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Rigel Pharmaceuticals USD 0 0 2024-09
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 0 0 2025-03